Social Proof: How BliskoMed Is Winning the Trust of Patients and the Healthcare Market

Since its commercial launch in January 2026, BliskoMed has proven that the healthcare sector desperately needed flexible, on-demand solutions. The past six months have been all about moving from validation to execution—rapidly expanding into new cities and bringing doctors directly to patients’ doorsteps. This physical presence builds real social proof, driving trust among patients, enterprise partners, and investors alike.
Back in April, we announced our investment in BliskoMed to support their vision for healthtech. Today, we’re thrilled to share that prominent business angels Tomasz Karwatka and Piotr Karwatka are joining the cap table, bringing valuable domain expertise and strategic capital to accelerate the next phase of growth.
Six Months of Aggressive Expansion
Nothing proves patient trust better than speed of execution. In just six months, BliskoMed has scaled far beyond its initial footprint in the Tricity area (Gdańsk, Gdynia, Sopot). In-home doctor visits and professional nursing care are now live across Poland’s major metropolitan hubs—including Gdańsk, Warsaw, Kraków, and Poznań—as well as their surrounding suburban areas.
This trust is quickly spilling over into the B2B sector. BliskoMed has established strategic partnerships with senior care facilities and insurance providers. For patients and families, this means seamless coverage under their existing health policies and eliminates the burden of transporting elderly relatives from care homes to brick-and-mortar clinics.
Industry-wide confidence in the model is also reflected in talent acquisition. The operational team has been bolstered by senior hires from leading healthtech platforms and hospital networks. Top-tier industry talent choosing to join BliskoMed validates the project’s maturity and ensures quality remains uncompromised as visit volume scales.
Investing in Healthtech: Where Real Value Is Created
The key to winning in modern healthtech lies in balancing software scalability with real-world operational execution. The BliskoMed team’s ability to seamlessly connect technology with field-level medical personnel—backed by hands-on investors—creates a resilient foundation for building a market leader.
Ultimately, lasting enterprise value isn’t built on business architecture alone. It emerges at the intersection of technology, capital, and operations, solving a genuine, daily human need—delivering fast, professional, and stress-free healthcare right where it matters most: at home.
